ANDREA WARBURTON: Open Payments
NPI 1588022560 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 54 payments from 14 companies in 2025. Trend: 2023 $221 · 2024 $712 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $193 |
| AstraZeneca Pharmaceuticals LP | 11 | $184 |
| ABBVIE INC. | 9 | $148 |
| Novo Nordisk Inc | 5 | $110 |
| Astellas Pharma US Inc | 3 | $57 |
| ViiV Healthcare Company | 2 | $52 |
| PFIZER INC. | 2 | $35 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $27 |
| Corcept Therapeutics | 1 | $23 |
Products named: AIRSUPRA, OTEZLA, Wegovy, VRAYLAR, UBRELVY, Veozah, APRETUDE, KRYSTEXXA.
Industry payments across NV — which companies pay providers there.
